On Friday, InterXion Holding NV (NYSE:INXN)’s shares declined -1.73% to $28.39.
InterXion Holding NV (INXN) Baker Capital has informed Interxion that it intends to make a pro rata distribution-in-kind of these shares right away to the partners of Baker Communications Fund II (Cayman) L.P. and Baker Communications Fund II L.P., which funds had made their initial acquisition of Interxion shares in 2000. Under the terms of the undertaking executed by Baker Capital in support of the projected transaction between Interxion and Telecity Group plc, it was contemplated that Baker Capital would make a full distribution of its shares to its partners upon the closing of the transaction. The distribution is being made now following the termination of the projected transaction with Telecity Group plc and the related undertaking executed by Baker Capital. Following the distribution, Baker Capital will own shares constituting less than 1% of the outstanding ordinary shares of Interxion.
Interxion stated that this distribution will not have any effect upon the total number of shares outstanding.
InterXion Holding N.V. provides carrier and cloud neutral colocation data center services in Europe. The company enables its customers to connect to a range of telecommunications carriers, Internet service providers, and other customers. Its data centers act as content, cloud, and connectivity hubs that facilitate the processing, storage, sharing, and distribution of data, content, applications, and media between carriers and customers.
CarMax, Inc (NYSE:KMX)’s shares gained 0.88% to $73.71.
CarMax, Inc (KMX) declared the webcast and conference call access information for forthcoming events.
June 19, 2015 – First Quarter Fiscal Year 2016 Earnings Conference Call
On June 19, CarMax will release sales and earnings for the first quarter ended May 31, 2015, and will host a conference call for investors at 9:00 a.m. ET.
CarMax, Inc., through its auxiliaries, operates as a retailer of used vehicles in the United States. The company operates in two segments, CarMax Sales Operations and CarMax Auto Finance. It offers customers a range of makes and models of used vehicles, counting domestic and imported vehicles; sells vehicles that do not meet its retail standards to licensed dealers through on-site wholesale auctions; and provides extended protection plans to customers at the time of sale.
At the end of Friday’s trade, NiSource Inc. (NYSE:NI)‘s shares dipped -0.85% to $45.29.
NiSource Inc. (NI) declared that its Board of Directors elected Deborah A. “Deb” Henretta to the Board, effective upon the separation of Columbia Pipeline Group (CPG) from NiSource, which is predictable to happen on July 1, 2015.
Ms. Henretta presently serves as Group President of Global e-Commerce at the Procter & Gamble Co., counting serving as Head of Global Beauty Care, a role she held since 2012. She has held various senior positions throughout several P&G sectors, counting Division President of Global Baby/Toddler & Adult Care and Division Vice President of Fabric Conditioners and Bleach.
NiSource Inc., an energy holding company, provides natural gas, electricity, and other products and services in the United States. It operates through three segments: Gas Distribution Operations, Columbia Pipeline Group Operations, and Electric Operations. The Gas Distribution Operations segment offers natural gas service and transportation to residential, commercial, and industrial customers.
Laboratory Corp. of America Holdings (NYSE:LH), ended its Friday’s trading session with -0.32% loss, and closed at $119.35.
Laboratory Corp. of America Holdings (LH) eclared the expanded availability of its proprietary specimen collection and handling software, LabCorp AccuDraw®, to all clients through its website at www.LabCorp.com. Combining on-screen visual cues with step-by-step tutorials, AccuDraw is an innovative tool designed to guide the health care professional who collects patient specimens throughout the specimen collection process. AccuDrawassists to facilitate collection and appropriate stabilization of the correct specimen type and sample volume. This technology-enabled solution leads to fewer errors in specimen collection and processing, a reduced chance of delays in testing, and a lower likelihood of having a patient undergo a second visit to a health care professional for further specimen collection. AccuDraw has been used in LabCorp’s patient service centers and by LabCorp’s phlebotomists located in client locations for over five years. AccuDrawhas formerly only been, and will continue to be, accessible to LabCorp clients through the LabCorp Beacon® application.
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
